Last reviewed · How we verify
Vcf Contraceptive Pre-Filled Applicators (NONOXYNOL)
At a glance
| Generic name | NONOXYNOL |
|---|---|
| Sponsor | Mayer Labs Inc |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- prevention of pregnancy
Common side effects
Key clinical trials
- AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment (NA)
- The K-Map Study, Global Prevalence of KC
- Effectiveness of SNAPPS in Family Medicine Residency Program (NA)
- Ovulation Double Check (Proov) Verification and Usability Testing
- The Contraceptive Efficacy and Safety of an Intravaginal Acetic Acid Thermoreversible Gel on Chinese Women. (PHASE2)
- Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel (PHASE3)
- Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage (NA)
- A Study of Nonoxynol-9 (N-9) and HIV Infection (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vcf Contraceptive Pre-Filled Applicators CI brief — competitive landscape report
- Vcf Contraceptive Pre-Filled Applicators updates RSS · CI watch RSS
- Mayer Labs Inc portfolio CI